Valeant Pharmaceuticals International and Turing Pharmaceuticals AG, both under congressional investigation in the US over drug price increases, were focused on making money before helping patients, according to members of Congress.

The chief executive of a US pharmaceutical company has defended his firm’s decision to raise the price of an Aids medication by more than 5,000% practically overnight.